Download Full Text (270 KB)
Introduction -2.5 to 4.7 million people in the United States have active Hepatitis C (HCV) infections. •Chronic HCV infection is linked to substantial morbidity including cirrhosis and liver failure. •Oral direct-acting antivirals (DAA) yield sustained virologic response in 90 to 95% of individuals. •Many patients eligible for DAA therapy have not received treatment.
Maine Medical Center
Waters, Colin T.; Cutler, Anya K.; Thakarar, Kinna; and Fairfield, Kathleen, "Factors Associated with Chronic Hepatitis C Direct-acting Antiviral Prescriptions in Maine" (2022). Costas T. Lambrew Research Retreat 2022. 22.
2022 Lambrew Retreat